UBS Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11
| Closed | -$95 | – | 9056 |
|
|
2024
Q2 | $95 | Sell |
11
-109
| -91% | -$941 | ﹤0.01% | 8006 |
|
|
2024
Q1 | $1.05K | Sell |
120
-7
| -6% | -$61 | ﹤0.01% | 7078 |
|
|
2023
Q4 | $946 | Buy |
127
+36
| +40% | +$268 | ﹤0.01% | 7249 |
|
|
2023
Q3 | $526 | Buy |
91
+89
| +4,450% | +$514 | ﹤0.01% | 7293 |
|
|
2023
Q2 | $12 | Hold |
2
| – | – | ﹤0.01% | 7639 |
|
|
2023
Q1 | $13 | Sell |
2
-448
| -100% | -$2.91K | ﹤0.01% | 8350 |
|
|
2022
Q4 | $3.04K | Buy |
450
+448
| +22,400% | +$3.02K | ﹤0.01% | 8382 |
|
|
2022
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 9888 |
|
|
2022
Q2 | $0 | Sell |
1
-182
| -99% | – | ﹤0.01% | 9922 |
|
|
2022
Q1 | $4K | Sell |
183
-316
| -63% | -$6.91K | ﹤0.01% | 8287 |
|
|
2021
Q4 | $30K | Buy |
+499
| New | +$30K | ﹤0.01% | 6299 |
|
|
2021
Q3 | – | Sell |
-36
| Closed | -$6K | – | 8914 |
|
|
2021
Q2 | $6K | Sell |
36
-178
| -83% | -$29.7K | ﹤0.01% | 7367 |
|
|
2021
Q1 | $41K | Buy |
+214
| New | +$41K | ﹤0.01% | 5742 |
|